bioAffinity Technologies, Inc. - Common Stock, par value $0.007 per share (BIAF) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2022 to Q3 2025

Type / Class
Equity / Common Stock, par value $0.007 per share
Symbol
BIAF on Nasdaq
Shares outstanding
28,694,438
Price per share
$0.17
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
25,000
Total reported value
$4,228
Share change
-337,316
Value change
-$96,869
Number of holders
1
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of bioAffinity Technologies, Inc. - Common Stock, par value $0.007 per share (BIAF) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Crumly Richard K. 11% $1,446,200 3,213,777 Richard K. Crumly 07 May 2025

As of 30 Sep 2025, 1 institutional investors reported holding 25,000 shares of bioAffinity Technologies, Inc. - Common Stock, par value $0.007 per share (BIAF). This represents 0.09% of the company’s total 28,694,438 outstanding shares.

Institutional Holders of bioAffinity Technologies, Inc. - Common Stock, par value $0.007 per share (BIAF) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q3 25,000 $4,228 -$96,869 $0.17 1
2025 Q2 362,316 $104,049 -$25,253 $0.29 17
2025 Q1 512,251 $132,483 -$26,697 $0.26 17
2024 Q4 535,651 $497,418 +$62,248 $0.91 16
2024 Q3 467,790 $973,004 +$137,185 $2.08 14
2024 Q2 399,694 $863,338 +$345,631 $2.16 17
2024 Q1 239,689 $484,422 +$181,105 $2.02 14
2023 Q4 156,046 $230,527 +$54,950 $1.47 12
2023 Q3 119,176 $139,690 +$26,167 $1.16 10
2023 Q2 96,694 $176,951 -$10,384 $1.83 7
2023 Q1 102,367 $193,473 +$54,521 $1.89 6
2022 Q4 83,455 $133,528 -$13,621 $1.60 5
2022 Q3 66,055 $192,000 +$192,000 $2.91 4